Competition & Markets Authority
Drug firms admit to colluding in order to keep prices up
Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up.
The move comes as part of a competition law investigation by the Competition and Markets Authority (CMA) into drug firms King Pharmaceuticals Limited, Alissa Healthcare Research Limited and Lexon (UK) Limited.
In June 2019, the CMA issued a statement of objections provisionally finding that the 3 suppliers had exchanged commercially sensitive information about prices, volumes and entry plans in order to keep prices up.
Nortriptyline is prescribed by the NHS and relied on by thousands of patients every month to relieve the symptoms of depression. NHS spending on the drug peaked at £38 million in 2015.
King and Alissa have now admitted breaking competition law by exchanging strategic and competitively-sensitive information with one another and with Lexon during periods between 2015 and 2017.
The CMA’s investigation into Lexon is ongoing as the firm denies involvement in the suspected infringement. Therefore, any infringement decision - which could lead to a fine - would be made at the end of the investigation.
For more information see the case page.
Original article link: https://www.gov.uk/government/news/drug-firms-admit-to-colluding-in-order-to-keep-prices-up
Latest News from
Competition & Markets Authority
Advice for shoppers after report highlights difficulties buying 'green' home heating31/05/2023 12:05:00
CMA will be carrying out further work looking into potential misleading practices in the green heating and insulation sector.
Meta offers to limit use of other businesses’ ad data to address CMA concerns29/05/2023 10:05:00
In response to competition concerns raised by the CMA, Meta has offered commitments not to use competitors’ advertising data for its Facebook Marketplace online classified ad service. It will do this by implementing new technical systems and training for staff.
Demolition company director disqualified for 7 years for bid rigging and compensation payments25/05/2023 16:05:00
The CMA has secured the disqualification of a further demolition company director for illegal cartel behaviour, bringing the total number to 4.
CMA provisionally finds 5 banks broke competition law on UK bonds24/05/2023 13:05:00
The CMA has provisionally found these banks unlawfully exchanged sensitive information regarding UK government bonds in one-to-one online chats.
Vet business takeovers raise competition concerns for pet owners18/05/2023 14:10:00
CMA’s initial investigation into Medivet’s purchase of multiple independent vet businesses highlights potential price and quality issues
CMA update on action to help contain cost of living pressures15/05/2023 13:20:00
The CMA today updated on the action it is taking to help contain rising cost of living pressures in road fuel and groceries.
Satellite merger approved after in-depth CMA probe09/05/2023 12:10:00
Following a provisional clearance in March, the CMA is now allowing the proposed merger of Viasat and Inmarsat to go ahead.
Merger could worsen vehicle salvage service options for UK car insurers05/05/2023 16:10:00
The CMA has provisionally found that Copart’s completed purchase of Hills Motors raises competition concerns in the supply of vehicle salvage services in the UK.